American Pharmacy News
  • People
  • Innovation
  • Regulatory
  • Industry
  • Federal Issues
  • State Issues
  • Directory
  • People
  • Innovation
  • Regulatory
  • Industry
  • Federal Issues
  • State Issues
  • Directory
  • Home
  • »
  • Stories
  • »
  • Industry

APRICUS HEALTH: Partners with Medicare Advantage Plan Devoted Health and Full-Service Retail Pharmacy Liton Rx

American Pharmacy News Reports | Nov 6, 2020

Apricus Health members now have access to one of the fastest growing Medicare Advantage plans in the United States, free and discounted medications, and free same-day delivery Read More »

UPSHER-SMITH LABORATORIES, LLC: Amina Abubakar Of Charlotte, North Carolina Named 2020 Willard B. Simmons Independent Pharmacist Of The Year

American Pharmacy News Reports | Oct 31, 2020
Amina Abubakar, PharmD, NCPA’s 2020 Willard B. Simmons Independent Pharmacist of the Year Award Winner

Known as the "Mother Theresa of Healthcare", Abubakar Earns Award for Tireless Service to Community Health and Advancing Pharmacy Education Read More »

ENDO: To Acquire BioSpecifics to Enhance Profitability of XIAFLEX® and Qwo™

American Pharmacy News Reports | Oct 30, 2020

Endo to acquire BioSpecifics in an accretive all-cash transaction Read More »

Pharmaceutical companies hope to bolster confidence in COVID-19 vaccine

American Pharmacy News Reports | Oct 30, 2020
PhRMA organizations have joined together to build confidence in the COVID-19 vaccine process.

While there are concerns about the unforeseen health impacts of a vaccine for COVID-19, a coalition of pharmaceutical companies has joined together to build confidence in the process and end result. Read More »

FDA issues warning for pregnant women who take some pain, fever medications after 20 weeks

Benjamin Kibbey | Oct 25, 2020
The U.S. Food and Drug Administration recently issued a Drug Safety Communication requiring a labeling change on some over-the-counter pain medications for pregnant women past 20 weeks.

The U.S. Food and Drug Administration (FDA) recently released a warning for pregnant mothers regarding a family of medications that includes ibuprofen, naproxen, diclofenac, celecoxib and other nonsteroidal anti-inflammatory drugs (NSAIDs). Read More »

CORDANT HEALTH SOLUTIONS: Earns High Net Promoter Score of 85 From Patients in Managed Pharmacy Program

American Pharmacy News Reports | Oct 18, 2020

Cordant Health Solutions®, a leader in providing innovative tools for monitoring patients in addiction treatment programs, announced that it earned a Net Promoter Score (NPS) of 85 among patients in its managed pharmacy program. Read More »

American Pharmacists Association launches program to prepare pharmacists for new health guidelines

American Pharmacy News Reports | Oct 14, 2020
The program was designed to ensure that pharmacists are in compliance with new health guidelines.

The American Pharmacists Association (APhA) has partnered with Washington State University College of Pharmacy and Pharmaceutical Sciences to launch a program to prepare pharmacists to meet education requirements to administer vaccinations to children ages three to 18, according to a news release on the APhA's website. Read More »

FDA approves drug combination that treats mesothelioma

Trina Thomas | Oct 8, 2020
The FDA approved the use of Opdivo and Yervoy to treat mesothelioma.

The U.S. Food and Drug Administration (FDA) announced the approval of Opdivo (nivolumab) combined with Yervoy (ipilimumab) for first-line treatment of adults who have malignant pleural mesothelioma that cannot use alternative methods for removal such as surgery. Read More »

AAM releases yearly report on generics, biosimilar drugs

American Pharmacy News Reports | Oct 3, 2020
The U.S. health care system saved $313 billion in 2019 from generics and biosimilar drugs, including $96 billion in Medicare savings and $48.5 billion in savings to Medicaid.

The U.S. health care system saved $313 billion in 2019 from generics and biosimilar drugs, including $96 billion in Medicare savings and $48.5 billion in savings to Medicaid. Read More »

FDA approves use of XELJANZ on children

Elyse Kelly | Oct 3, 2020
The FDA approved the use of Pfizer's drug XELJANZ on children over two years old with polyarticular course juvenile idiopathic arthritis.

The U.S. Food and Drug Administration (FDA) recently approved Pfizer’s drug XELJANZ (tofacitinib) for treatment of polyarticular course juvenile idiopathic arthritis (pcJIA). Read More »

ASHP launches its first National Survey of Health-System Specialty Pharmacy Practice

American Pharmacy News Reports | Sep 23, 2020
The survey was designed to provide insight into the current state of specialty pharmacy practice.

The American Society of Health-System Pharmacists (ASHP) recently launched its first National Survey of Health-System Specialty Pharmacy Practice, according to a press release by the ASHP. Read More »

ASHP responds to petition calling for an end to gender discrimination in the pharmacy industry

Andy Nghiem | Sep 17, 2020
The ASHP spoke out in support of the petition and said that it supports all of its members and colleagues.

The American Society of Health-System Pharmacists (ASHP) recently released a response to a petition calling for an end to gender inequality in the clinical pharmacy industry. Read More »

Biopharmaceutical industry confident in COVID-19 vaccine, researchers say

American Pharmacy News Reports | Sep 17, 2020
The biopharmaceutical industry is confident it will beat COVID-19 as it ensures highest standards in research, testing and manufacturing a vaccine for the virus.

Pharmaceutical Research and Manufacturers of America President and CEO Stephen Ubl said the biopharmaceutical industry is confident it will beat COVID-19 as it ensures the highest standards in research, testing and manufacturing a vaccine for the virus. Read More »

SURFACE PHARMACEUTICALS: Strengthens Leadership Team as Clinical Programs Advance in Eye Care

American Pharmacy News Reports | Sep 6, 2020

Expanding Board of Directors to Add to Commercial Expertise Read More »

APHA: 12 Other Pharmacy Organizations Call for Tier 1 Priority Status for Pharmacists in Planning for the COVID-19 Vaccine

American Pharmacy News Reports | Sep 6, 2020

The American Pharmacists Association and 12 other pharmacy organizations told a special committee of the National Academies of Science, Engineering and Medicine (NASEM) that pharmacists should be given tier 1 priority status in the allocation and distribution of COVID-19 vaccine(s). Read More »

ARBOR PHARMACEUTICALS, LLC: Confirms Availability of Triptodur® (triptorelin) for Patients with Central Precocious Puberty

American Pharmacy News Reports | Aug 29, 2020

Company orders additional product amid reported industry shortage Read More »

Physician groups recommend topical NSAIDs for acute pain

American Pharmacy News Reports | Aug 27, 2020
The American College of Physicians and the American Academy of Family Physicians calls for topical NSAIDs to be used as a first-line treatment for acute pain lasting no more than four weeks from non–low back, musculoskeletal injuries.

For patients with non-low back, musculoskeletal injuries, non-steroidal anti-inflammatory drugs should be a first-line treatment for acute pain that lasts no more than four weeks, according to a new guideline from the American College of Physicians and the American Academy of Family Physicians. Read More »

Cost of sharing assistance program threatened by administration actions

Michael Pineda | Aug 25, 2020
Cost of sharing assistance has proved beneficial in helping chronically ill patients save money on much-needed medication.

The high costs of medical care are well-documented, but those battling significant illnesses have found a measure of economic relief through manufacturer cost-sharing assistance programs. Read More »

PhRMA exec optimistic on COVID-19 vaccine

David Beasley | Aug 25, 2020
A system that allows for collaboration is the key to a successful COVID-19 vaccine, a PhRMA manufacturers executive said.

The push for a COVID-19 vaccine is “remarkably positioned to succeed,” Jenny Bryant, executive vice president of policy and research for the Pharmaceutical Research and Manufacturers of America (PhRMA), said. Read More »

KARMANOS CANCER INSTITUTE: Karmanos Specialty Pharmacy (KSP) receives full, three-year accreditation from the Utilization Review Accreditation Commission (URAC)

American Pharmacy News Reports | Aug 23, 2020

Karmanos Specialty Pharmacy (KSP) is pleased to announce that it has received full accreditation from the Utilization Review Accreditation Commission (URAC). This accreditation is valid for three years. Read More »

  • «
  • 1
  • 2 (current)
  • 3
  • 4
  • 5
  • ...
  • 31
  • 32
  • »
Trending

Sally Greenberg, JD, Chief Executive Officer, National Consumers League

National Consumers League announces poll showing support for 340B drug pricing reform

Mary Holland, CEO of CHD

Poll finds majority want pharma accountable for vaccine injuries

Danea Horn, Researcher, University of California

Researcher on 340B: Physicians 'select patients who require more intensive pharmaceutical treatments after joining the 340B program'

Shaun Noorian, CEO of Empower Pharmacy

Empower Pharmacy challenges Eli Lilly tirzepatide patent before U.S. Patent Trial and Appeal Board

Mary Holland, CEO of Children'S Health Defense

FDA mandates updated warnings on heart risks for Pfizer, Moderna vaccines

Copyright © 2025 American Pharmacy News. All Rights Reserved.

  • About
  • Contact
  • Privacy Policy
  • Terms of Service

Alerts Sign-up